Generation Operating Income vs Cost Of Revenue Analysis

GBIO Stock

USD 1.40 0.03 2.19%

Generation Bio financial indicator trend analysis is much more than just examining Generation Bio latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Generation Bio is a good investment. Please check the relationship between Generation Bio Operating Income and its Cost Of Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Operating Income vs Cost Of Revenue

Operating Income vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Generation Bio Operating Income account and Cost Of Revenue. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Generation Bio's Operating Income and Cost Of Revenue is -0.7. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Generation Bio Co, assuming nothing else is changed. The correlation between historical values of Generation Bio's Operating Income and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Generation Bio Co are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Operating Income i.e., Generation Bio's Operating Income and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.7

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Operating Income

Operating Income is the amount of profit realized from Generation Bio operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Generation Bio Co is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Generation Bio income statement and represents the costs associated with goods and services Generation Bio provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Generation Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Generation Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

As of the 26th of November 2024, Selling General Administrative is likely to drop to about 31.7 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 34.2 M

	2023	2024 (projected)
Depreciation And Amortization	5.3M	3.8M
Interest Income	12.0M	12.5M

Depreciation And Amortization Interest Income

Generation Bio fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		0.6	0.72	0.98	0.78	0.99	0.93	-0.51	-0.85	-0.2	0.82	0.93	-0.48	0.88	0.99	0.2	0.97	0.82	0.48	-0.61	0.94	0.68	0.94	-0.33	0.98	0.6
Other Current Liab	0.6		0.76	0.54	0.7	0.65	0.63	0.0	-0.71	0.13	0.28	0.62	-0.73	0.61	0.56	0.58	0.71	0.62	0.56	-0.25	0.68	0.04	0.59	0.05	0.54	0.81
Total Current Liabilities	0.72	0.76		0.63	0.68	0.7	0.81	0.06	-0.95	0.16	0.43	0.81	-0.54	0.78	0.67	0.78	0.76	0.81	0.5	-0.24	0.9	0.08	0.8	0.17	0.63	0.98
Total Stockholder Equity	0.98	0.54	0.63		0.76	0.98	0.86	-0.55	-0.77	-0.35	0.81	0.86	-0.47	0.79	0.99	0.08	0.95	0.74	0.5	-0.74	0.9	0.75	0.88	-0.5	1.0	0.5
Other Liab	0.78	0.7	0.68	0.76		0.79	0.83	-0.3	-0.79	-0.09	0.57	0.83	-0.85	0.74	0.73	0.13	0.84	0.9	0.41	-0.49	0.81	0.62	0.78	-0.23	0.76	0.63
Net Tangible Assets	0.99	0.65	0.7	0.98	0.79		0.91	-0.48	-0.83	-0.26	0.76	0.91	-0.5	0.86	0.99	0.19	0.98	0.79	0.56	-0.64	0.92	0.67	0.92	-0.38	0.98	0.58
Property Plant And Equipment Net	0.93	0.63	0.81	0.86	0.83	0.91		-0.38	-0.92	0.06	0.74	1.0	-0.53	0.97	0.88	0.32	0.94	0.96	0.41	-0.34	0.93	0.57	0.99	-0.02	0.86	0.69
Net Debt	-0.51	0.0	0.06	-0.55	-0.3	-0.48	-0.38		0.05	-0.02	-0.86	-0.37	0.27	-0.23	-0.55	0.46	-0.36	-0.26	0.37	0.38	-0.24	-0.69	-0.34	0.41	-0.55	0.17
Retained Earnings	-0.85	-0.71	-0.95	-0.77	-0.79	-0.83	-0.92	0.05		0.01	-0.52	-0.92	0.53	-0.9	-0.79	-0.59	-0.89	-0.9	-0.59	0.37	-0.97	-0.33	-0.92	-0.02	-0.77	-0.89
Accounts Payable	-0.2	0.13	0.16	-0.35	-0.09	-0.26	0.06	-0.02	0.01		0.06	0.05	-0.15	0.04	-0.28	0.41	-0.22	0.14	-0.58	0.78	-0.14	-0.5	-0.02	0.86	-0.35	0.22
Cash	0.82	0.28	0.43	0.81	0.57	0.76	0.74	-0.86	-0.52	0.06		0.74	-0.43	0.6	0.82	-0.05	0.68	0.63	-0.1	-0.46	0.66	0.68	0.71	-0.29	0.81	0.3
Non Current Assets Total	0.93	0.62	0.81	0.86	0.83	0.91	1.0	-0.37	-0.92	0.05	0.74		-0.52	0.97	0.88	0.32	0.94	0.96	0.41	-0.34	0.93	0.57	0.99	-0.02	0.86	0.69
Non Currrent Assets Other	-0.48	-0.73	-0.54	-0.47	-0.85	-0.5	-0.53	0.27	0.53	-0.15	-0.43	-0.52		-0.37	-0.45	-0.19	-0.54	-0.66	-0.12	0.36	-0.54	-0.31	-0.42	0.14	-0.47	-0.59
Other Assets	0.88	0.61	0.78	0.79	0.74	0.86	0.97	-0.23	-0.9	0.04	0.6	0.97	-0.37		0.82	0.37	0.91	0.91	0.52	-0.23	0.88	0.48	0.98	0.08	0.79	0.66
Cash And Short Term Investments	0.99	0.56	0.67	0.99	0.73	0.99	0.88	-0.55	-0.79	-0.28	0.82	0.88	-0.45	0.82		0.15	0.95	0.75	0.48	-0.68	0.91	0.7	0.9	-0.43	0.99	0.54
Net Receivables	0.2	0.58	0.78	0.08	0.13	0.19	0.32	0.46	-0.59	0.41	-0.05	0.32	-0.19	0.37	0.15		0.26	0.32	0.34	0.19	0.46	-0.55	0.33	0.53	0.08	0.85
Common Stock Total Equity	0.97	0.71	0.76	0.95	0.84	0.98	0.94	-0.36	-0.89	-0.22	0.68	0.94	-0.54	0.91	0.95	0.26		0.85	0.62	-0.58	0.95	0.63	0.95	-0.28	0.95	0.66
Common Stock Shares Outstanding	0.82	0.62	0.81	0.74	0.9	0.79	0.96	-0.26	-0.9	0.14	0.63	0.96	-0.66	0.91	0.75	0.32	0.85		0.33	-0.25	0.87	0.51	0.92	0.07	0.74	0.72
Short Term Investments	0.48	0.56	0.5	0.5	0.41	0.56	0.41	0.37	-0.59	-0.58	-0.1	0.41	-0.12	0.52	0.48	0.34	0.62	0.33		-0.49	0.58	0.17	0.48	-0.29	0.5	0.49
Non Current Liabilities Total	-0.61	-0.25	-0.24	-0.74	-0.49	-0.64	-0.34	0.38	0.37	0.78	-0.46	-0.34	0.36	-0.23	-0.68	0.19	-0.58	-0.25	-0.49		-0.55	-0.67	-0.36	0.92	-0.74	-0.18
Capital Surpluse	0.94	0.68	0.9	0.9	0.81	0.92	0.93	-0.24	-0.97	-0.14	0.66	0.93	-0.54	0.88	0.91	0.46	0.95	0.87	0.58	-0.55		0.48	0.93	-0.19	0.9	0.81
Other Current Assets	0.68	0.04	0.08	0.75	0.62	0.67	0.57	-0.69	-0.33	-0.5	0.68	0.57	-0.31	0.48	0.7	-0.55	0.63	0.51	0.17	-0.67	0.48		0.56	-0.66	0.75	-0.08
Other Stockholder Equity	0.94	0.59	0.8	0.88	0.78	0.92	0.99	-0.34	-0.92	-0.02	0.71	0.99	-0.42	0.98	0.9	0.33	0.95	0.92	0.48	-0.36	0.93	0.56		-0.05	0.88	0.67
Total Liab	-0.33	0.05	0.17	-0.5	-0.23	-0.38	-0.02	0.41	-0.02	0.86	-0.29	-0.02	0.14	0.08	-0.43	0.53	-0.28	0.07	-0.29	0.92	-0.19	-0.66	-0.05		-0.5	0.22
Net Invested Capital	0.98	0.54	0.63	1.0	0.76	0.98	0.86	-0.55	-0.77	-0.35	0.81	0.86	-0.47	0.79	0.99	0.08	0.95	0.74	0.5	-0.74	0.9	0.75	0.88	-0.5		0.5
Property Plant And Equipment Gross	0.6	0.81	0.98	0.5	0.63	0.58	0.69	0.17	-0.89	0.22	0.3	0.69	-0.59	0.66	0.54	0.85	0.66	0.72	0.49	-0.18	0.81	-0.08	0.67	0.22	0.5

Click cells to compare fundamentals

Generation Bio Account Relationship Matchups

Generation Bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	42.1M	294.2M	476.8M	376.3M	374.8M	302.1M
Other Current Liab	6.9M	11.0M	7.6M	4.3M	16.5M	9.4M
Total Current Liabilities	9.2M	11.2M	18.8M	19.2M	39.9M	41.9M
Total Stockholder Equity	(98.6M)	268.0M	381.7M	282.5M	203.1M	182.5M
Net Tangible Assets	(98.6M)	268.0M	381.7M	282.5M	324.9M	174.3M
Property Plant And Equipment Net	21.8M	23.8M	91.0M	81.4M	95.7M	58.3M
Net Debt	(15.1M)	(62.9M)	(294.3M)	(11.5M)	31.4M	33.0M
Retained Earnings	(108.5M)	(189.0M)	(308.1M)	(444.8M)	(571.4M)	(542.8M)
Accounts Payable	2.3M	267K	2.0M	662K	2.3M	1.7M
Cash	15.1M	62.9M	375.1M	93.2M	66.4M	113.7M
Non Current Assets Total	24.0M	26.4M	97.6M	89.2M	102.1M	63.4M
Non Currrent Assets Other	87K	588K	864K	2.1M	698K	863.6K
Other Assets	2.1M	2.6M	6.6M	7.8M	9.0M	4.7M
Cash And Short Term Investments	15.1M	262.3M	375.1M	279.1M	264.4M	233.0M
Net Receivables	448K	252K	403K	395K	4.1M	4.4M
Common Stock Shares Outstanding	46.2M	27.3M	56.3M	58.1M	64.5M	49.9M
Liabilities And Stockholders Equity	42.1M	294.2M	476.8M	376.3M	374.8M	302.1M
Non Current Liabilities Total	131.6M	14.9M	76.2M	74.6M	131.7M	73.0M
Capital Surpluse	9.9M	457.0M	689.9M	727.3M	836.4M	878.3M
Other Current Assets	2.6M	5.4M	7.4M	7.5M	290K	275.5K
Other Stockholder Equity	9.9M	162.8M	689.9M	727.3M	774.2M	434.4M
Total Liab	140.7M	26.1M	95.0M	93.8M	171.6M	119.6M
Net Invested Capital	(98.6M)	268.0M	381.7M	282.5M	203.1M	182.5M
Property Plant And Equipment Gross	21.8M	23.8M	25.9M	22.2M	115.3M	121.1M
Total Current Assets	18.2M	267.7M	379.2M	287.0M	272.6M	238.6M
Net Working Capital	9.0M	256.5M	360.4M	267.9M	232.7M	219.4M
Property Plant Equipment	21.8M	23.8M	25.9M	22.2M	25.5M	21.6M

Pair Trading with Generation Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Generation Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Generation Stock

0.64	A	Agilent Technologies Sell-off Trend	Pair Corr
0.85	ME	23Andme Holding	Pair Corr
0.71	VALN	Valneva SE ADR	Pair Corr
0.73	JNJ	Johnson Johnson Sell-off Trend	Pair Corr

Moving against Generation Stock

0.57	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.54	RNXT	RenovoRx	Pair Corr
0.35	KZR	Kezar Life Sciences	Pair Corr
0.33	KEP	Korea Electric Power	Pair Corr

The ability to find closely correlated positions to Generation Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Generation Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Generation Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Generation Bio Co to buy it.

The correlation of Generation Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Generation Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Generation Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Generation Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Generation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Generation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Generation Bio Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Generation Bio Co Stock:

How To Invest In Generation

Details

Is Generation Stock a good investment?

Details

What is Generation Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.19)

Revenue Per Share

0.28

Quarterly Revenue Growth

2.52

Return On Assets

(0.19)

Return On Equity

(0.86)

The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Generation Operating Income vs Cost Of Revenue Analysis

Operating Income vs Cost Of Revenue

Operating Income vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Operating Income

Cost Of Revenue

Generation Bio fundamental ratios Correlations

Generation Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Generation Bio fundamental ratios Accounts

Pair Trading with Generation Bio

Moving together with Generation Stock

Moving against Generation Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Invested Capital	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Net Tangible Assets	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity
Cash And Short Term Investments	+ 0.99	Net Tangible Assets

Capital Surpluse	- 0.97	Retained Earnings
Retained Earnings	- 0.95	Total Current Liabilities
Other Stockholder Equity	- 0.92	Retained Earnings
Non Current Assets Total	- 0.92	Retained Earnings
Retained Earnings	- 0.92	Property Plant And Equipment Net
Common Stock Shares Outstanding	- 0.9	Retained Earnings